Lava Therapeutics N.V. (LVTX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.2500 -0.0100 (-0.79%) 04/30/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.2500 unch (unch) 15:59 ET
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select FieldsSymbol | LVTX | COEP | CVKD | ||
Company | Lava Therapeutics N.V. | Coeptis Therapeutics Hldgs Inc | Cadrenal Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.2600 | 10.00 | 16.50 | ||
High | 1.2600 | 10.00 | 16.67 | ||
Low | 1.2000 | 7.00 | 16.05 | ||
Last | 1.2500 | 8.40 | 16.42 | ||
Change | -0.0100 | -1.52 | -0.36 | ||
% Change | -0.79% | -15.32% | -2.15% | ||
Volume | 73,100 | 322,000 | 14,500 | ||
20-Day Average Volume | 57,230 | 101,440 | 20,015 | ||
Previous Close | 1.2600 | 9.92 | 16.78 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | No | No | ||
Technicals | |||||
20-Day Moving Average | 1.2308 | 9.77 | 16.16 | ||
20-Day Raw Stochastic | 53.99% | 34.29% | 47.56% | ||
20-Day Relative Strength | 50.60% | 44.57% | 46.90% | ||
Weighted Alpha | -45.85 | -17.98 | +42.58 | ||
Today's Opinion | 24% Sell | 24% Buy | 24% Buy | ||
Previous Opinion | 8% Sell | 64% Buy | 24% Buy | ||
Last Month's Opinion | 24% Sell | 40% Buy | 48% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -8.09% since 04/23/25 | -26.96% since 04/23/25 | -2.73% since 04/23/25 | ||
Low | 1.2000 on 04/30/25 | 6.26 on 04/25/25 | 16.05 on 04/30/25 | ||
High | 1.4000 on 04/24/25 | 12.50 on 04/24/25 | 17.50 on 04/28/25 | ||
1-Month | |||||
%Chg | -3.10% since 03/28/25 | -10.45% since 03/28/25 | -11.05% since 03/28/25 | ||
Low | 1.0300 on 04/08/25 | 6.26 on 04/25/25 | 14.05 on 04/07/25 | ||
High | 1.4375 on 04/23/25 | 12.50 on 04/24/25 | 19.03 on 04/02/25 | ||
3-Month | |||||
%Chg | +28.71% since 01/30/25 | -34.43% since 01/30/25 | -13.72% since 01/30/25 | ||
Low | 0.8502 on 02/12/25 | 6.26 on 04/25/25 | 14.05 on 04/07/25 | ||
High | 1.5100 on 03/07/25 | 13.50 on 02/19/25 | 22.90 on 02/26/25 | ||
6-Month | |||||
%Chg | -34.90% since 10/30/24 | +101.05% since 10/30/24 | +0.18% since 10/30/24 | ||
Low | 0.8502 on 02/12/25 | 2.31 on 12/31/24 | 10.20 on 12/13/24 | ||
High | 2.0000 on 12/03/24 | 13.70 on 01/30/25 | 22.90 on 02/26/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 33,144 | 33,380 | 32,553 | ||
Shares Outstanding, K | 26,305 | 3,365 | 1,940 | ||
Annual Sales | 11,980,000 | 0 | 0 | ||
Annual Net Income | -25,110,000 | -10,880,000 | -10,650,000 | ||
Last Quarter Sales | 4,990,000 | 0 | 0 | ||
Last Quarter Net Income | -3,970,000 | -3,010,000 | -4,190,000 | ||
60-Month Beta | 0.46 | -0.68 | 1.42 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.14 on 03/28/25 | -1.00 on 11/13/24 | -2.74 on 03/13/25 | ||
Latest Earnings Date | 05/20/25 | 05/09/25 | 05/08/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |